There is almost no chance anything truly new and material will be disclosed by the CFO, here — given that the year end earnings release conference was just 13 days ago — but I’ll check in on it, just the same.
Given that the Leerink firm just downgraded Merck about a week ago, there might be some testy lines of questioning.
. . . .Merck & Co., Inc. CFO Peter Kellogg at Leerink Swann Global Healthcare Conference Wednesday, February 13, 2013 11:30 a.m. ET. . . .